Immediate Impact

26 standout
Sub-graph 1 of 10

Citing Papers

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
2 intermediate papers

Works of Andrés Emanuelli being referenced

Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
2023
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
2021

Author Peers

Author Last Decade Papers Cites
Andrés Emanuelli 176 104 43 25 217
Babak Mohammadi 147 86 49 28 256
L. Jiun 131 99 56 21 264
Peter Lou 197 109 31 22 245
Pritha Roy 184 103 47 22 244
Sancy Low 194 101 64 21 282
Alson E. Braley 132 37 38 23 204
Sameera Nayak 160 51 11 25 211
Hossein Nazari Khanamiri 236 92 33 14 265
Muhammad A. Ahad 144 112 32 20 257
A. Ray Irvine 178 78 36 14 283

All Works

Loading papers...

Rankless by CCL
2026